IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FRANCESCHINI, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.097
EU - Europa 7.132
AS - Asia 1.625
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 14
AF - Africa 12
AN - Antartide 1
Totale 18.911
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.056
IT - Italia 3.209
CN - Cina 1.477
UA - Ucraina 1.441
DE - Germania 791
IE - Irlanda 362
GB - Regno Unito 293
FR - Francia 270
FI - Finlandia 265
PL - Polonia 130
SE - Svezia 101
BE - Belgio 77
RU - Federazione Russa 77
IN - India 51
CA - Canada 38
TR - Turchia 34
ES - Italia 19
RO - Romania 18
NL - Olanda 15
EU - Europa 14
VN - Vietnam 14
AU - Australia 13
MK - Macedonia 11
CH - Svizzera 10
GR - Grecia 9
IR - Iran 9
BR - Brasile 8
LU - Lussemburgo 8
SA - Arabia Saudita 6
JP - Giappone 5
SG - Singapore 5
UG - Uganda 5
AT - Austria 4
BG - Bulgaria 4
IL - Israele 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
EG - Egitto 3
JO - Giordania 3
MU - Mauritius 3
AM - Armenia 2
DK - Danimarca 2
HK - Hong Kong 2
ID - Indonesia 2
IQ - Iraq 2
LT - Lituania 2
PH - Filippine 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
KZ - Kazakistan 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SI - Slovenia 1
VE - Venezuela 1
Totale 18.911
Salva come PNG Salva come JPEG
Città #
Fairfield 1.569
Woodbridge 1.140
Jacksonville 1.085
Houston 796
Ashburn 630
Cambridge 623
Ann Arbor 586
Seattle 564
Wilmington 563
Princeton 553
Chandler 476
Nanjing 350
Dublin 294
Beijing 262
Milan 188
Brescia 147
Helsinki 132
Warsaw 125
Nanchang 121
Rome 121
San Diego 107
Des Moines 106
Hebei 105
Shenyang 99
Changsha 78
Florence 77
Brussels 73
Tianjin 73
Jinan 67
Jiaxing 63
London 55
Verona 54
Hangzhou 47
Bergamo 44
Trieste 44
Dearborn 42
San Francisco 42
Lancaster 38
Kunming 32
Ningbo 32
Udine 27
Toronto 25
Genova 24
Padova 23
Taizhou 23
Bologna 22
Haikou 22
Lanzhou 22
Zhengzhou 22
Kocaeli 21
Syracuse 21
Menlo Park 20
Torino 19
Turin 19
Nürnberg 18
Reggio Nell'emilia 18
Mumbai 17
Redwood City 17
Boardman 16
Pisa 16
Guangzhou 15
Norwalk 15
Orange 15
Dong Ket 14
Monmouth Junction 14
Trento 14
Genoa 13
Modena 13
San Mateo 13
Strasbourg 13
Bari 11
Dallas 11
Ferrara 11
Paris 11
Pordenone 11
Rho 11
Desio 10
Islington 10
Mountain View 10
Napoli 10
Palermo 10
Pozzuolo Del Friuli 10
Augusta 9
Chiswick 9
Falkenstein 9
Melbourne 9
Taiyuan 9
Turriaco 9
Cosenza 8
Fiumicino 8
Perugia 8
Pescara 8
Cagliari 7
Catania 7
Changchun 7
Duncan 7
Lecco 7
Lucera 7
Manresa 7
Redmond 7
Totale 12.422
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 1.800
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.324
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 149
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 143
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 139
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 139
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 136
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 126
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 124
Antiphospholipid antibodies mediate autoimmunity against dying cells. 114
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 114
The clinico-serological spectrum of overlap myositis 114
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 113
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 111
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 111
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 110
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 109
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 109
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 108
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 107
Autoimmune polyendocrine Syndromes 106
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 105
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 105
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 104
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 103
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 102
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 101
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 101
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 101
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 100
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 100
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 100
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: The positive experience of a national multicentre study 99
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 98
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 98
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 98
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 97
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 97
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 97
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 97
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 95
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 94
Incidence of antiperinuclear factor in patients with psoriatic arthritis. 94
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 94
Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. 92
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 92
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 90
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 90
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 90
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 90
Antiperinuclear factor in psoriatic arthropathy 89
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 89
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 88
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 88
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 88
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference 87
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 86
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 86
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 86
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 85
Pathogenetic associations of maternal anti-Ro/SSA antibodies. 85
Determination of antibodies to extractable nuclear antigens by commercial kits: a multicenter study 84
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 83
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 83
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 82
Anti-Ro/SSA and La/SSB antibodies 82
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 82
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 81
Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety 81
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus 81
Serologic profile and mortality rates of scleroderma renal crisis in Italy 81
Myositis autoantibodies and clinical phenotypes 81
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 81
Update on Antiphospholipid Syndrome: Ten Topics in 2017 81
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 80
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 79
Cardiological features in idiopathic inflammatory myopathies. 79
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 78
Incidence of antiperinuclear factor in sera of patients with psoriatic arthritis 77
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 76
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 76
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 76
Retention of a bile acid analogue in the enterohepatic circulation (EHC) in primary biliary cirrhosis (PBC): comparison with normal controls and effect of bile acid treatment. 74
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 74
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 73
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 73
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 73
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 73
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 73
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 72
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 72
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 71
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 71
Transient neonatal bradycardia without heart block associated with anti-Ro antibodies 71
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. 71
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 70
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 70
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 70
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 70
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 70
Totale 12.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.013 0 0 52 80 235 78 212 266 66 221 397 406
2019/20205.026 782 162 187 528 285 510 414 538 384 748 166 322
2020/20214.004 94 438 162 444 243 469 145 448 464 475 393 229
2021/20223.024 183 399 141 179 165 202 202 235 194 298 274 552
2022/20232.335 349 39 51 99 192 568 53 235 395 64 158 132
2023/2024471 164 90 217 0 0 0 0 0 0 0 0 0
Totale 19.356